Acquisition Strengthens Aspire Pharma’s Strategic Portfolio

Aspire Pharma has announced the acquisition of Charlwood Pharma Ltd, a privately owned company specialising in the research & development of niche generic medicines. The acquisition marks the culmination of a successful multi-year collaboration…

Menopause and Skin Health: Insights from Aspire Pharma and National Eczema Society

Research conducted by Aspire Pharma and National Eczema Society in October 2024, revealed the often-hidden impact of menopause on skin health, with many women encountering unexpected issues like dry skin and eczema as they undergo hormonal changes.   The…

Medicines Optimisation Centricity – Reimagining Value in the Patient Pathway

Executive Summary: Medicines Optimisation Centricity – Reimagining Value in the Patient Pathway Overview This white paper, developed by HSJ Advisory in partnership with Aspire Pharma, presents a compelling case for transforming medicines…